LY2523355

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2523355, covering 2013-01-28 to 2017-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2523355 in Participants With Breast Cancer [Phase 2]